Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double blind study of SC12267 (35 mg) plus methotrexate vs methotrexate alone in rheumatoid arthritis
2009-012953-39Phase 2Completed
- Sponsor
- 4SC AG
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing SC12267 + methotrexate with Placebo + methotrexate (2 arms). Primary endpoint: ACR20 response at week 13. Started Jul 2009; status: completed.
02
Drugs
vidofludimus calcium
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2009-012953-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012953-39.